Shree Pacetronix

Shree Pacetronix Interest Expense

The Interest Expense of Shree Pacetronix (527005.BO) as of Oct 31, 2026 is -5.82 M INR. In the previous year, Interest Expense was -3.65 M INR — a change of 59.42% (lower).

Interest Expense

-5.82 MINR

YoY

59.42%

Last updated:

Interest Expense of Shree Pacetronix is 2025 -5.82 M INR. Interest Expense of Shree Pacetronix was 2024 -3.65 M INR. It decreases by 59.42% lower compared to the previous year.

The Shree Pacetronix Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2020
-3.61 M INR
Jan 1, 2021
-3.32 M INR
Jan 1, 2022
-2.77 M INR
Jan 1, 2023
-2.47 M INR
Jan 1, 2024
-3.65 M INR
Jan 1, 2025
-5.82 M INR
The Shree Pacetronix Interest Expense history
YEARInterest ExpenseYoY
-5.82 MINR+59.42%
-3.65 MINR+47.81%
-2.47 MINR-10.74%
-2.77 MINR-16.63%
-3.32 MINR-8.10%
-3.61 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shree Pacetronix Stock analysis

What does Shree Pacetronix do? Shree Pacetronix Ltd. generates revenue through the sale of implantable cardiac pacemakers and related medical devices. The company's product portfolio includes multi-programmable pacemakers such as Ventralite 940 +/ Tiranga, Pinnacle 8820, and Tiranga 302, as well as rate responsive pacemakers like Charak DDDR and Pinnacle-R SSIR + Model 297. Bivent pacemakers such as Trinity R and external pacemakers including Indus I SSB and Zeus-1 are also sold. Additional products consist of pacing system analyzers, physician corners, and pacing leads like temporary leads, Screw-in lead P12 Model 3844 VB/ 3744VB, IS1 Bipolar Lead 3851 VB, and Atrial J Bipolar Lead 3851 VB. The company serves the Life Saving Devices segment with a focus on India and the Rest of the World, targeting healthcare providers and medical institutions requiring cardiac pacemaker solutions. Shree Pacetronix Ltd. operates under the Life Saving Devices segment, offering specialized medical equipment for cardiac care. Its subsidiary Shree Coratomic Limited supports the company's operations. The primary buyers are healthcare facilities and medical institutions in India and international markets, purchasing pacemakers and associated devices for patient treatment. Products are distributed through medical supply channels to hospitals and clinics specializing in cardiology. The firm's revenue streams are derived from the direct sale of its branded medical devices. Key products include the Ventralite 940 +/ Tiranga, Pinnacle 8820, Tiranga 302, Charak DDDR, Pinnacle-R SSIR + Model 297, Trinity R, Indus I SSB, Zeus-1, Smart-E programmer, and various pacing leads. These products are sold to healthcare providers globally, with significant market presence in India and the Rest of the World. The company's business model centers on providing essential cardiac care equipment through its comprehensive product range. Shree Pacetronix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shree Pacetronix stock

Interest Expense of Shree Pacetronix is -5.82 M INR in 2025.

Interest Expense of Shree Pacetronix changed from -3.65 M INR to -5.82 M INR, representing a 59.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Shree Pacetronix since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Shree Pacetronix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Shree Pacetronix

All Key Metrics — Shree Pacetronix